Genomic Profiling of Circulating Tumor DNA from Patients with Extensive-Stage Small Cell Lung Cancer Identifies Potentially Actionable Alterations

Comprehensive genomic profiling may help uncover potentially actionable alterations in small cell lung cancer (SCLC) patients who have progressed on standard chemotherapy. However, tissue procurement may be extremely challenging for extensive-stage patients. We aimed to investigate the possibility o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jing, Wang, Xiangyun, Lu, Jingli, Chen, Hui, Zhao, Xiaochen, Gao, Chan, Bai, Yuezong, Zhang, Qiwen, Fu, Xiaomin, Zhang, Xiaojian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317512/
https://www.ncbi.nlm.nih.gov/pubmed/34335926
http://dx.doi.org/10.7150/jca.55134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317512/
https://www.ncbi.nlm.nih.gov/pubmed/34335926
http://dx.doi.org/10.7150/jca.55134

Ejemplares similares